Targeting myeloid cells with bispecific antibodies as novel immunotherapies of cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting myeloid cells with bispecific antibodies as novel immunotherapies of cancer

Published:2022-07-19 Issue:8 Volume:22 Page:983-995
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Sewnath Celine A.N.¹²³,Behrens Leonie M.¹²³,van Egmond Marjolein¹²³⁴

Affiliation:

1. Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam De Boelelaan, Amsterdam, The Netherlands

2. Cancer Biology and Immunology Program, Cancer Centre Amsterdam, Amsterdam, The Netherlands

3. Cancer Immunology Program, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands

4. Department of Surgery, Amsterdam UMC, Vrije Universiteit Amsterdam De Boelelaan, Amsterdam, The Netherlands

Funder

the KWF Dutch Cancer Society

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2022.2098675

Reference148 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Hallmarks of Cancer: The Next Generation

3. Cancer immunoediting: from immunosurveillance to tumor escape

4. Immune checkpoint signaling and cancer immunotherapy

5. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A real-time antibody-dependent cellular phagocytosis assay by live cell imaging;Journal of Immunological Methods;2024-08

2. Mechanism-Driven Design of Multispecific Antibodies for Targeted Disease Treatment;Annual Review of Chemical and Biomolecular Engineering;2024-07-24

3. Bridging the gap with multispecific immune cell engagers in cancer and infectious diseases;Cellular & Molecular Immunology;2024-05-24

4. Constructing immune and prognostic features associated with ADCP in hepatocellular carcinoma and pan-cancer based on scRNA-seq and bulk RNA-seq;Frontiers in Immunology;2024-05-07

5. Regulatory considerations in the design, development and quality of monoclonal antibodies and related products for the diagnosis and treatment of cancer;Frontiers in Oncology;2024-04-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3